(Q52918646)

9 May 2018

title

Estimating the prevalence of infectious agents using pooled samples: biometrical considerations. (English)

1 reference

9 May 2018

author name string

Abel U

series ordinal

1

1 reference

9 May 2018

Schosser R

series ordinal

2

1 reference

9 May 2018

Süss J

series ordinal

3

1 reference

9 May 2018

publication date

1 December 1999

1 reference

9 May 2018

Zentralblatt fur Bakteriologie : international journal of medical microbiology

published in

1 reference

9 May 2018

volume

289

1 reference

9 May 2018

issue

5-7

1 reference

9 May 2018

page(s)

550-563

1 reference

9 May 2018

Human immunodeficiency virus testing for patient-based and population-based diagnosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models.

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Point estimates and confidence intervals for infection rates using pooled organisms in epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

The Detection of Defective Members of Large Populations

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Estimating sporozoite rates by examining pooled samples of mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Beyond simple pooling for HIV screening

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Screening for anti-HIV and HBsAg in pooled sera from a clinical chemistry section as a tool for epidemiological survey

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Study of HIV antibody screening for blood donors by a pooling-serum method

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Successful use of pooled sera to estimate HIV antibody seroprevalence and eliminate all positive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

A prospective study of a serum-pooling strategy in screening blood donors for antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Pooling blood donor samples to reduce the cost of HIV-1 antibody testing

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Bayesian inference on prevalence using a missing-data approach with simulation-based techniques: applications to HIV screening

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Relevance of antibody content and test format in HIV testing of pooled sera

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Use of pooling, and outpatient laboratory specimens in an anonymous seroprevalence survey of HIV infection in British Columbia, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Group Testing To Eliminate Efficiently All Defectives in a Binomial Sample

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Epidemiology and ecology of tick-borne encephalitis in the eastern part of Germany between 1960 and 1990 and studies on the dynamics of a natural focus of tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Tick-borne encephalitis virus (TBEV)-specific RT-PCR for characterization of natural foci of TBE and for other applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Reducing the cost of HIV antibody testing

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

Estimation of infection rates in population of organisms using pools of variable size

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2899%2980009-7

7 January 2021

10.1016/S0934-8840(99)80009-7

Identifiers

DOI

0 references

1 reference

9 May 2018